Musings about medical school: could I get in today?

J Obstet Gynaecol Can

Published: February 2006

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1701-2163(16)32058-8DOI Listing

Publication Analysis

Top Keywords

musings medical
4
medical school
4
school today?
4
musings
1
school
1
today?
1

Similar Publications

The rate of change in clinical indicators can predict the progression of hepatitis B virus-related acute-on-chronic preliver failure.

Medicine (Baltimore)

October 2024

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

The objective of this study was to investigate the predictors and predictive model construction of the progression of HBV-Pre.Acute-on-chronic liver failure (ACLF), a total of 133 patients with HBV-Pre.ACLF was divided into the progressive group (52 patients) and the recovery group (81 patients) according to whether they progressed to ACLF or not.

View Article and Find Full Text PDF

Background: Burn injuries may cause gastrointestinal dysfunction leading to intestinal barrier dysfunction, abdominal compartment syndrome, and acute mesenteric ischemia. In the absence of major vascular occlusion, non-occlusive mesenteric ischemia (NOMI) often occurs in critically ill intensive-care burn patients.

Methods: A retrospective descriptive analysis of the burn registry of the Department of Plastic, Aesthetic, Hand and Reconstructive Surgery of Hannover Medical School was performed from 1st January 2018 to 1st May 2024.

View Article and Find Full Text PDF

Phosphodiesterase 5 and its inhibitors with ischemic heart disease: a Mendelian randomization analysis and a real-world study.

Eur Heart J Cardiovasc Pharmacother

October 2024

Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.

Background: Accumulating studies reported that several phosphodiesterases (PDEs) inhibitors might have cardiovascular benefits.

Objectives: This study aimed to explore the relationship between genetically-predicted PDEs and ischemia heart disease via drug target Mendelian randomization (MR) approach, and then examine the effect of inhibitors of identified target on the outcomes by using real-world data.

Methods: In the two-sample MR study, the expression of genes encoding PDEs was used to proxy the level of PDEs and available expression quantitative trait loci (eQTLs) for each target gene were identified as the genetic instruments.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the safety and effectiveness of catheter-directed thrombolysis (CDT) using rt-PA in patients with symptomatic peripheral artery disease from January 2013 to December 2020.
  • Of the 1238 patients treated, serious adverse events occurred in 41.3%, with bleeding being the most common complication at 25.4%, and notable rates of limb salvage at 91.6% and 88.8% after 12 and 24 months, respectively.
  • Key predictors for complications included increasing age, the use of certain medications (abciximab and alprostadil), and the duration of the lysis treatment, highlighting a significant risk associated with CDT despite its high success rate.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates prenatal consultation and integrated management of fetal pulmonary valve anomalies (PVA) in China, emphasizing the need for timely intervention after birth.
  • Researchers analyzed data from 30 fetal PVA cases at Peking University People's Hospital between January 2019 and March 2023, finding varied conditions like pulmonary atresia with intact ventricular septum and pulmonary stenosis.
  • Outcomes showed that most patients received effective postnatal treatments, with the majority recovering well; however, some families chose pregnancy termination based on the severity of the condition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!